Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma

Nestor A Molfino, Piotr Kuna, Jonathan A Leff, Chad K Oh, D Singh, Marlene Chernow, Brian Sutton, Geoffrey Yarranton

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Medicine and Dentistry